Urs Hagemann
Company: Bayer
Job title: Head of Targeted Radiopharmaceuticals
Seminars:
Roundtable Discussion – Understanding How to Choose the Correct Oncological Target to Adapt Your TRP to Changing Tumor Expressions 11:10 am
Navigating changing tumour expression Reflecting on how this expression affects target selection Analysing what makes a good target given changing tumour expressionRead more
day: Day 1 - Track A (AM)
Moulding Your TRP to Work Around the Challenges Associated With Novel Targets 9:50 am
day: Day 1 - Track A (AM)
Advancing Bayer’s (Pre)clinical TRT Pipeline 8:00 am
• Reviewing preclinical assets and modalities • Diving into combinations • Exploring the clinical assetsRead more
day: Conference Day 1